Healthcare -
Biotechnology - NASDAQ - US
$ 6.14
0.656 %
$ 520 M
Market Cap
-2.5
P/E
VERV - OPERATING EXPENSES
Operating Expenses VERV - Verve Therapeutics, Inc.
235 M
LAST VALUE
64.25%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR